+148.5%
MRNA vs QID
-28.4%
+176.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | QID | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +2.3% | -1.6% | +1.7% |
| 7D | -8.2% | +2.7% | -11.0% | -7.2% |
| 30D | +125.6% | +3.3% | +122.2% | +129.1% |
| 3M | +197.1% | -5.5% | +202.6% | +182.8% |
| 6M | +148.5% | -28.4% | +176.9% | +99.5% |
| All | +148.5% | -28.4% | +176.9% | +99.5% |
Cumulative growth
Daily Returns
Daily percentage return beside QID.
Daily Out/Under-Performance
Portfolio return minus QID return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × QID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded QID wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling